Taken together, our data demonstrate that PERK-C/EBPδ-dependent factors secreted from cancer cells after exposure to thapsigargin modulate myeloid cell gene expression through activation of CXCR1/2 receptors. This evidence concerns the gene CEBPD and cancer.